Iradimed (IRMD) EPS (Basic) (2013 - 2026)

Iradimed (IRMD) has 14 years of EPS (Basic) data on file, last reported at $0.46 in Q1 2026.

• EPS (Basic) for Q1 2026 came in at $0.46, up 24.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.86 (up 18.47% YoY), and the FY2025 annual result was $1.77, up 16.45% from the prior year.
• EPS (Basic) retreated to $0.46 in Q1 2026 per IRMD's latest filing, from $0.51 in the prior quarter.
• Over five years, EPS (Basic) peaked at $0.51 in Q4 2025 and troughed at $0.2 in Q1 2022.
• A 5-year average of $0.36 and a median of $0.37 in 2025 frame the typical range for EPS (Basic).
• On a YoY basis, EPS (Basic) climbed as much as 116.67% in 2022 and fell as far as 9.37% in 2022.
• A 5-year view of EPS (Basic) shows it stood at $0.29 in 2022, then climbed by 24.14% to $0.36 in 2023, then advanced by 13.89% to $0.41 in 2024, then rose by 24.39% to $0.51 in 2025, then fell by 9.8% to $0.46 in 2026.
• Business Quant data shows IRMD's EPS (Basic) at $0.46 in Q1 2026, $0.51 in Q4 2025, and $0.44 in Q3 2025.